Such was the case in 2010, when France’s largest pharmaceutical company, Sanofi SA (SNY), decided to buy American biotechnology company Genzyme Transgenics Corp. At the time, Genzyme had ...

Transgenic Sciences lnc.—a startup that is banking on a ... Led by new CEO James Sherblom, formerly of Genzyme Corp., the firm aims to raise $5 million and augment its scientific staff as a result of ...

Genzyme of Cambridge, Massachusetts, faces millions in lost revenue from its top-selling specialty drugs Cerezyme and Fabrazyme as result of a viral contamination at its Allston, Massachusetts plant.